Medication info

Bajerol Tablet

Prescription medicationTablet경구Expired
Ingredient · strength
Bazedoxifene Acetate›22.6mgCholecalciferol Concentrate Powder›8mg
Manufacturer / importer
(주)테라젠이텍스
Appearance
Pink oblong film-coated tablet
Packaging
28 tablets (28 tablets/PTP)
Approval status
Expired

MFDS item code 201804006 · Approved 2018.10.11

This product's status changed to Expired on 2023.10.11. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Prevention of osteoporosis and vertebral fractures in postmenopausal women
Who takes it
Adults
Adult dose
Take 1 tablet once daily, regardless of meals.

Ingredients

Manufacturer
(주)테라젠이텍스

Efficacy & effects

Prevention of osteoporosis and vertebral fractures in postmenopausal women

  • Osteoporosis
View approved original text

This medication is used for the treatment and prevention of osteoporosis in postmenopausal women. It primarily reduces the occurrence of vertebral fractures and helps improve bone density, supporting bone health. However, its efficacy for non-vertebral fractures has not yet been definitively proven. Therefore, it is effective for patients at high risk of vertebral fractures. Overall, it is a treatment that contributes to the prevention of bone weakening and fractures.

How to take

Adult dose

Take 1 tablet once daily, regardless of meals.

Precautions

This medication may increase the risk of thrombosis in the blood, so it is not recommended for women at high risk of thrombosis. Especially after surgery or during prolonged immobility, this medication should be discontinued and resumed only when the patient can move again. This medication is intended for postmenopausal women only and is not recommended for premenopausal women. If uterine bleeding occurs during treatment, it is essential to seek medical attention. The use of this medication in patients with breast cancer or for the prevention of breast cancer is not recommended due to lack of established safety. It should not be used in individuals with an allergy to this medication, a history of thrombosis, pregnant women, those who may become pregnant, or nursing mothers. Additionally, patients with unexplained uterine bleeding or symptoms of endometrial cancer, hypercalcemia, or renal stones should avoid taking this medication. This medication contains lactose; thus, individuals with lactose intolerance should not take it. Patients with high triglycerides or problems with kidney or liver function need to exercise caution when using this medication and should follow their doctor’s instructions. Drowsiness or visual disturbances may occur during treatment, so caution is advised when driving or operating machinery. Additional vitamin D supplementation may be necessary for those at high risk of vitamin D deficiency, and calcium intake should be sufficient. In case of overdose, there is no specific antidote, and symptomatic treatment should be provided. If hypercalcemia symptoms appear, immediate consultation with medical personnel is required. This medication is not for use in children, and pregnant or nursing women should not take it. Medications should be stored out of the reach of children and kept in their original container for safety.

Side effects and when to seek care immediately

Serious side effects

Urticaria, deep vein thrombosis, pulmonary embolism, retinal vein thrombosis, severe allergic reactions, chest tightness, urticaria, rash, asthma, shortness of breath, respiratory failure, respiratory issues, cerebral infarction, cerebral hemorrhage, cerebral infarction, bradycardia, pyelonephritis, severe edema, generalized edema, edema accompanied by increased blood pressure, jaundice, liver abnormalities, sudden and very severe headache, seizures, confusion, visual abnormalities, paralysis, retinal hemorrhage, death, spinal stenosis, obstruction

Mild side effects

  • Drowsiness
  • flushing
  • leg cramps
  • dry mouth
  • rash
  • itching
  • muscle spasms
  • peripheral edema
  • increased blood triglycerides
  • elevated ALT
Show 23 more
  • elevated AST
  • decreased vision
  • blurred vision
  • photophobia
  • visual field defects
  • visual disturbances
  • dry eye
  • eyelid swelling
  • eyelid twitching
  • eye pain
  • eye edema
  • vomiting
  • gastritis
  • belching
  • allergic reactions
  • chest discomfort
  • leg pain
  • fever
  • swelling
  • facial swelling
  • changes in temperature sensation
  • lethargy
  • numbness

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent exposure to air or moisture. The recommended storage temperature is room temperature between 1 to 30 degrees Celsius.

Appearance and packaging

Appearance

Pink oblong film-coated tablet

Package unit

28 tablets (28 tablets/PTP)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.